Literature DB >> 9487143

The inhibition of cell signaling pathways by antitumor ether lipids.

G Arthur1, R Bittman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9487143     DOI: 10.1016/s0005-2760(97)00163-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


× No keyword cloud information.
  15 in total

1.  Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.

Authors:  P Escobar; V Yardley; S L Croft
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  In vitro antifungal activities of inhibitors of phospholipases from the fungal pathogen Cryptococcus neoformans.

Authors:  Ranjini Ganendren; Fred Widmer; Vatsala Singhal; Christabel Wilson; Tania Sorrell; Lesley Wright
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 3.  Perifosine: update on a novel Akt inhibitor.

Authors:  Joell J Gills; Phillip A Dennis
Journal:  Curr Oncol Rep       Date:  2009-03       Impact factor: 5.075

Review 4.  Structural insights into phospholipase C-β function.

Authors:  Angeline M Lyon; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2013-07-23       Impact factor: 4.436

5.  Genomic analysis of homotypic vacuole fusion.

Authors:  E Scott Seeley; Masashi Kato; Nathan Margolis; William Wickner; Gary Eitzen
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

6.  Canine leishmaniosis: in vitro efficacy of miltefosine and marbofloxacin alone or in combination with allopurinol against clinical strains of Leishmania infantum.

Authors:  Anna Maria Farca; B Miniscalco; P Badino; R Odore; P Monticelli; A Trisciuoglio; E Ferroglio
Journal:  Parasitol Res       Date:  2012-01-05       Impact factor: 2.289

7.  Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid.

Authors:  Stefan R Vink; Jan H M Schellens; Wim J van Blitterswijk; Marcel Verheij
Journal:  Invest New Drugs       Date:  2005-08       Impact factor: 3.850

8.  Inositoylated platelet-activating factor (Ino-C2-PAF) modulates dynamic lymphocyte-endothelial cell interactions and alleviates psoriasis-like skin inflammation in two complementary mouse models.

Authors:  Susann Forkel; Margarete Schön; Annette Hildmann; Anna Claßen; Swen-Malte John; Kerstin Danker; Michael P Schön
Journal:  J Invest Dermatol       Date:  2014-04-08       Impact factor: 8.551

9.  Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids.

Authors:  José M Jiménez-López; Pablo Ríos-Marco; Carmen Marco; Josefa L Segovia; María P Carrasco
Journal:  Lipids Health Dis       Date:  2010-03-25       Impact factor: 3.876

10.  Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug.

Authors:  F Javier Pérez-Victoria; Santiago Castanys; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.